Front-line bevacizumab in serous epithelial ovarian cancer: biomarker analysis of the FINAVAST trial.
Year: 2010
Type: article
Source: PubMed
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2145191418
